AAAAAA
Results:
1-19
|
Results: 19
Retinoids for ovarian cancer prevention: Laboratory data set the stage forthoughtful clinical trials
Authors:
Veronesi, U
Decensi, A
Citation: U. Veronesi et A. Decensi, Retinoids for ovarian cancer prevention: Laboratory data set the stage forthoughtful clinical trials, J NAT CANC, 93(7), 2001, pp. 486-488
Authors:
Dowsett, M
Bundred, NJ
Decensi, A
Sainsbury, RC
Lu, YL
Hills, MJ
Cohen, FJ
Veronesi, P
O'Brien, MER
Scott, T
Muchmore, DB
Citation: M. Dowsett et al., Effect of raloxifene on breast cancer cell Ki67 and apoptosis: A double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients, CANC EPID B, 10(9), 2001, pp. 961-966
Authors:
Guerrieri-Gonzaga, A
Baglietto, L
Johansson, H
Bonanni, B
Robertson, C
Sandri, MT
Canigiula, L
Lampreda, C
Diani, S
Lien, EA
Decensi, A
Citation: A. Guerrieri-gonzaga et al., Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial, CANC EPID B, 10(9), 2001, pp. 967-970
Authors:
Decensi, A
Johansson, H
Miceli, R
Mariani, L
Camerini, T
Cavadini, E
Di Mauro, MG
Barreca, A
Gonzaga, AG
Diani, S
Sandri, MT
De Palo, G
Formelli, F
Citation: A. Decensi et al., Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer, CANC EPID B, 10(10), 2001, pp. 1047-1053
Authors:
Camerini, T
Mariani, L
De Palo, G
Marubini, E
Di Mauro, MG
Decensi, A
Costa, A
Veronesi, U
Citation: T. Camerini et al., Safety of the synthetic retinoid fenretinide: Long-term results from a controlled clinical trial for the prevention of contralateral breast cancer, J CL ONCOL, 19(6), 2001, pp. 1664-1670
Authors:
Bonanni, B
Johansson, H
Gandini, S
Guerrieri-Gonzaga, A
Torrisi, R
Sandri, MT
Cazzaniga, M
Mora, S
Robertson, C
Lien, EA
Decensi, A
Citation: B. Bonanni et al., Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women, BREAST CANC, 69(1), 2001, pp. 21-27
Authors:
Torrisi, R
Decensi, A
Formelli, F
Camerini, T
De Palo, G
Citation: R. Torrisi et al., Chemoprevention of breast cancer with fenretinide, DRUGS, 61(7), 2001, pp. 909-918
Authors:
Veronesi, U
De Palo, G
Marubini, E
Costa, A
Mariani, L
Formelli, F
Decensi, A
Citation: U. Veronesi et al., Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?, J NAT CANC, 92(3), 2000, pp. 274-274
Authors:
Decensi, A
Torrisi, R
Bruno, S
Costantini, M
Curotto, A
Nicolo, G
Malcangi, B
Baglietto, L
Bruttini, GP
Gatteschi, B
Rondanina, G
Varaldo, M
Perloff, M
Malone, WF
Bruzzi, P
Citation: A. Decensi et al., Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point, CANC EPID B, 9(10), 2000, pp. 1071-1078
Authors:
Decensi, A
Costa, A
Citation: A. Decensi et A. Costa, Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer, EUR J CANC, 36(6), 2000, pp. 694-709
Authors:
Decensi, A
Bonanni, B
Rotmensz, N
Robertson, C
Guerrieri-Gonzaga, A
Mora, S
Diani, S
Cazzaniga, M
Costa, A
Citation: A. Decensi et al., Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study, EUR J CANC, 36, 2000, pp. S50-S51
Authors:
Bruno, S
Torrisi, R
Costantini, M
Baglietto, L
Fontana, V
Gatteschi, B
Melioli, G
Nicolo, G
Curotto, A
Malcangi, B
Bruttini, GP
Varaldo, M
Bruzzi, P
Decensi, A
Citation: S. Bruno et al., Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial, J CELL BIOC, 76(2), 2000, pp. 311-321
Authors:
Decensi, A
Bonanni, B
Guerrieri-Gonzaga, A
Torrisi, R
Manetti, L
Robertson, C
De Palo, G
Formelli, F
Costa, A
Veronesi, U
Citation: A. Decensi et al., Chemoprevention of breast cancer: The Italian experience, J CELL BIOC, 2000, pp. 84-96
Authors:
Baglietto, L
Torrisi, R
Arena, G
Tosetti, F
Gonzaga, AG
Pasquetti, W
Robertson, C
Decensi, A
Citation: L. Baglietto et al., Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer, CANCER DET, 24(4), 2000, pp. 369-375
Authors:
Torrisi, R
Mezzetti, M
Johansson, H
Barreca, A
Pigatto, F
Robertson, C
Decensi, A
Citation: R. Torrisi et al., Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-I, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial, INT J CANC, 87(4), 2000, pp. 601-605
Authors:
Veronesi, U
De Palo, G
Marubini, E
Costa, A
Formelli, F
Mariani, L
Decensi, A
Camerini, T
Del Turco, MR
Di Mauro, MG
Muraca, MG
Del Vecchio, M
Pinto, C
D'Aiuto, G
Boni, C
Campa, T
Magni, A
Miceli, R
Perloff, M
Malone, WF
Sporn, MB
Citation: U. Veronesi et al., Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer, J NAT CANC, 91(21), 1999, pp. 1847-1856
Authors:
Decensi, A
Robertson, C
Ballardini, B
Paggi, D
Guerrieri-Gonzaga, A
Bonanni, B
Manetti, L
Johansson, H
Barreca, A
Bettega, D
Costa, A
Citation: A. Decensi et al., Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women, EUR J CANC, 35(4), 1999, pp. 596-600
Authors:
Decensi, A
Gandini, S
Guerrieri-Gonzaga, A
Johansson, H
Manetti, L
Bonanni, B
Sandri, MT
Barreca, A
Costa, A
Robertson, C
Lien, EA
Citation: A. Decensi et al., Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women, J CL ONCOL, 17(9), 1999, pp. 2633-2638
Authors:
Decensi, A
Torrisi, R
Gozza, A
Severi, G
Bertelli, G
Fontana, V
Pensa, F
Carozzo, L
Traverso, A
Milone, S
Dini, D
Costa, A
Citation: A. Decensi et al., Effect of fenretinide on bone mineral density and metabolism in women withearly breast cancer, BREAST CANC, 53(2), 1999, pp. 145-151
Risultati:
1-19
|